Navigation Links
MedImmune Focused on Revolutionizing Cancer Care
Date:11/16/2010

GAITHERSBURG, Md., Nov. 16, 2010 /PRNewswire/ -- Today, MedImmune announced that researchers will present data from its oncology portfolio, including new clinical data, at two upcoming medical congresses in Europe and the United States.

"At MedImmune, we are thinking about cancer and treatment in new ways, using insights and understanding of the disease to discover breakthrough biologic therapies that can be used to treat specific cancers for the individual patient," said Jerry McMahon, Senior Vice President and Oncology Innovative Medicines Unit Leader.  "We are excited about the progress of the oncology portfolio and are looking forward to its advancement of multiple oncology products into expanded clinical studies in the near future."  

With innovative antibody and biologic technologies, the MedImmune Oncology pipeline is focusing on developing new therapies to eliminate cancer cells in more effective and targeted ways.  This research is addressing the key areas critical to the development and progression of cancer: immune-mediated killing, vascular modulation, growth factor, and survival signaling.  

"The identification of novel cancer drug targets and associated biologic markers has not only altered the way we view cancer, but is truly revolutionizing our standard of care," said Bahija Jallal, Executive Vice President Research and Development at MedImmune.  "It is this research, with products like moxetumomab pasudotox (CAT-8015), that will help develop more effective solutions to targeting malignant tumor cells and providing a more personalized approach to medicine."

New data presentations

Four MedImmune-sponsored posters are being presented at the 22nd EORTC-NCI-AACR symposium on "Molecular Targets and Cancer Therapeutics" starting on Tuesday, November 16 in Berlin.  EORTC-NCI-AACR is a joint meeting of the European Organisation for Research and Treatment of Cancer, the National Cance
'/>"/>

SOURCE MedImmune
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MedImmune to Present Five Abstracts on RSV at Pediatric Academic Societies Annual Meeting
2. MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference & Exhibition
3. MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
4. MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
5. MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
6. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
7. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
8. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
9. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
10. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
11. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... /PRNewswire/--  Apexigen, Inc. , a biopharmaceutical company ... of cancer and other life-threatening diseases, announced today it ... at the Cavendish Global Health Impact Forum taking place ... in La Jolla, California . The ... and foundations develop and implement their individual pro-social impact ...
(Date:5/6/2015)... -- Eli Lilly and Company (NYSE: LLY ) ... and device innovation center in Cambridge, Massachusetts ... attract top scientists and bioengineers, as well as enhance ... Lilly Cambridge Innovation Center, a makerspace located in Kendall ... to explore how emerging technologies and connectivity can advance ...
(Date:5/6/2015)... GERMANTOWN, Md. , May 6, 2015 ... neural stem cell technology to develop small molecule and ... the appointment of Jonathan Lloyd Jones to ... th . Mr. Lloyd Jones ... of corporate finance and business development experience.   Most recently, ...
Breaking Medicine Technology:Apexigen Selected to Present at Cavendish Global Health Impact Forum 2Apexigen Selected to Present at Cavendish Global Health Impact Forum 3Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 2Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4
(Date:5/6/2015)... 06, 2015 Experienced Vancouver air conditioning ... announced that they will now conduct their cooling services, ... in addition to commercial and residential units. Strata complex ... a lot of technical knowledge as well as a ... installation we will take away any old air conditioning ...
(Date:5/6/2015)... Chesapeake Regional Medical Center is the ... acquire Intuitive Surgical, Inc.’s latest model of the ... enhanced surgical technique capabilities, which can be used ... spectrum of specialties. Its advancements allow patients less ... times. , “As the only independent, community-based hospital ...
(Date:5/6/2015)... Prime Pacific Health Innovations, the ... announce a new series of universal, one-time-use speculum ... footprint while improving treatment efficacy and saving therapists ... the world’s first waste hose designed specifically for ... claims the company’s president, Mr. Delmar Vogel. , ...
(Date:5/6/2015)... 2015 The Beryl Institute announces the ... Patient Experience Journal (PXJ), an international, open access, peer-reviewed ... and improving patient experience. The second volume of PXJ ... globally, helps align the voices engaged and provides the ... in association with The Beryl Institute, Volume 2, Issue ...
(Date:5/6/2015)... Animals make just as good friends as they ... your health. An Ohio veterinarian has been observing ... with health advantages of owning a pet. , “When animals ... pet ownership, there are proven health benefits for people-- including ... of the Animal Medical Center of Streetsboro said. ...
Breaking Medicine News(10 mins):Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3
... LOS ANGELES, June 8 Approximately 70% of men and women ... the recession began and 80% are nervous about their long term ... right now; there,s no shortage of things to be anxious and ... said Lucinda Bassett, Founder of the Midwest Center for Stress and ...
... Research conducted under the direction of Melinda Sothern, PhD, ... Health Sciences Center New Orleans School of Public Health, ... young as seven years old will be presented at ... in New Orleans. Dr. Sothern,s group is the first ...
... 45 million Americans suffer from headaches annually , , NEW ... Foundation (NHF), EHE International is helping raise awareness about headaches, which ... approach, the NHF and EHE are featuring "You ... and Your ... 10 Rockefeller Plaza, for the month of June, to coincide with ...
... June 8 Medical travel facilitator Companion Global Healthcare ... overseas network, creating more options for its employer groups ... lower than those in the United States. , ... and Klinikum Chemnitz in Chemnitz, Germany, means Companion Global ...
... Pa., June 8 ViroPharma Incorporated (Nasdaq: VPHM ... to its board of directors. , , Dr. Baldino ... and leadership to ViroPharma. He is the chief executive ... Inc., an international biopharmaceutical company in Chester County, Pennsylvania. ...
... Management Genetic Test that Provides Evidence-Based Guidance on Best ... , WALTHAM, Mass., June 8 Interleukin Genetics, Inc. ... introduction of its new Inherent Health(TM) brand of genetic ... weight management that identifies an individual,s genetic tendencies for ...
Cached Medicine News:Health News:Midwest Center for Stress and Anxiety Releases New Program, The Solution to Controlling Stress and Worry 2Health News:Midwest Center for Stress and Anxiety Releases New Program, The Solution to Controlling Stress and Worry 3Health News:LSUHSC researchers first to document early signs for diabetes in kids as young as 7 2Health News:LSUHSC researchers first to document early signs for diabetes in kids as young as 7 3Health News:EHE International Supports the National Headache Foundation 2Health News:Companion Global Healthcare Inc. Offers Additional Hospital Choices to Employers, Individuals Looking to Save on Fully Credentialed Health Care 2Health News:ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors 2Health News:ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors 3Health News:Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to Wellness 2Health News:Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to Wellness 3Health News:Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to Wellness 4Health News:Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to Wellness 5
Elmed BC 50 M/M is an all purpose bipolar coagulator with a macro and micro mode. In the micro mode, the unit is ideally suitable for wet-field coagulation in ophthalmology, neurosurgery and other mi...
...
...
...
Medicine Products: